Axinn Attorneys Win 2021 Antitrust Writing Awards
June 30, 2021
Axinn is pleased to announce that the below articles authored or co-authored by Axinn lawyers have won a 2021 Concurrences Antitrust Writing award.
- Business Article (Cross-border Issues subcategory): "Do You Have to Put Up With That? Legal Protections in the Context of Antitrust Law Investigations in the U.S. and E.U.," Nicholas Gaglio, Lindsey Strang, Susan Zhu, Dr. Lukas Aberle and Dr. Christian Steinle, Compliance Berater (April 28, 2020) (English publication pending)
- Business Article (Intellectual Property subcategory): "Antitrust Treatment of Acceleration Provisions in Hatch-Waxman Settlements," Michael Keeley and Cristina Fernandez, FDLI’s Update Magazine (Winter 2020)
- Business Article (Mergers subcategory): "Another Way to Skin the Cat? Perspectives on Using Section 2 to Challenge the Acquisition of Nascent Competitors," Jimmy Moore and Timothy Snyder, The Threshold (Fall 2020)
The decisions were the result of a five-month process involving more than 50 international antitrust experts reviewing more than 600 articles. All winners were announced on June 30 at a virtual reception.
To subscribe to our publications, click here.
Featured Insights
Featured Insights
CCWC 21st Annual Career Strategies Conference
Speaking Engagement
SCCE 23rd Annual Compliance & Ethics Institute
Speaking Engagement
Antitrust
HNBA/VIA Annual Convention 2025
Sponsorship
Antitrust
Key Appellate Decisions Shaping Antitrust Strategy
Webinar
Antitrust
ACI 12th Annual Summit for Women Leaders in Life Sciences Law
Speaking Engagement
Intellectual Property
National LGBTQ+ Bar Association Lavender Law Conference and Career Fair 2025
Sponsorship
National Bar Association 100th Annual Convention and Exhibits
Sponsorship
Antitrust
Axinn Attorneys Named to the 2025 Lawdragon 500 X – The Next Generation Guide
Awards & Recognitions
Keeping Pace: Updates in Cartel Enforcement
Webinar
Antitrust
Hanging in the Balance: Supreme Court Declines to Decide the Uninjured Class Member Question in Labcorp v. Davis
Axinn Viewpoints
Antitrust